Guobang Medicine has established an internal-external interactive innovation platform system. Internally, it is centered around the two major research institutes in Zhejiang and Shandong, and collaborates with academician workstations, postdoctoral workstations, provincial technical centers, provincial drug research institutes, high-tech enterprises, and other high-level cooperative platforms to form a complete process R&D capability for health active substances. Externally, it deepens the collaboration between industry, academia and research, jointly building R&D platforms with universities such as Lanzhou University, Zhejiang University, Shanghai Jiao Tong University, Jiangnan University, Nanjing University, and Zhejiang University of Technology. At the same time, it collaborates with international enterprises such as Bayer, Abbott, Mylan, TEVA, CHEMO, Novartis, Sandoz, Alembic, Dr. Reddy, and Cipla, leveraging international certification systems to achieve alignment of technology and standards, creating an open and collaborative innovation ecosystem, and continuously empowering technological upgrades and product innovations.